Two-day stress-rest lower limbs perfusion scan in patients referred for myocardial perfusion imaging

Document Type : Original Article

Authors

1 Research Center for Nuclear Medicine, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Introduction: Peripheral Vascular Disease (PVD) is a major cause of morbidity and is associated with Coronary Artery Disease (CAD). We aimed to perform Lower Limb Perfusion Scan (LLPS) in patients referred for Myocardial Perfusion Imaging (MPI) and estimate prevalence of PVD in subgroups with normal and abnormal MPI results. We also compared quantitative indices of LLPS in patients with and without abnormal MPI results with semi-quantitative QPS indices.
Methods:120 patients referred for MPI entered the study. Exercise or dipyridamole infusion was used as stress modality. After 99mTc-MIBI injection at peak stress, whole body posterior views and planar images from thighs and calves were obtained. Gated MPI was done subsequently. Rest phase was performed the following day. LLPS was analyzed visually and quantitatively.
Results:In patients with abnormal and normal MPI results, LLPS revealed 22.58% and 1.92% prevalence of PVD in exercise subgroup (P-Value=0.004) and 50.00% and 10.52% in dipyridamole subgroup (P-Value= 0.013), respectively. Both of these different prevalence were statistically significant. In exercise subgroup, mean ranks of Stress Index (Is) for all lower limb regions were statistically significantly greater in patients with normal MPI result. Also, among patients who had ischemia in exercise-rest MPI, negative correlations were seen between Is and Rest Index (Ir) of all regions and QPS quantitative indices.
Conclusion: LLPS with 99mTc-MIBI, combined with MPI is a feasible method to detect lower limbs ischemia, especially in patients with abnormal MPI results. Correlating quantitative indices of LLPS with MPI-QPS also reflect coexistence of CAD and PVD.

Keywords

Main Subjects

References

  1. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care. 1998 Dec;21(12):2161-77.
  2. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001 Oct 3;286(13):1599-606.
  3. Mohler ER 3rd. Peripheral arterial disease: identification and implications. Arch Intern Med. 2003 Oct 27;163(19):2306-14.
  4. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003 Dec;26(12):3333-41.
  5. Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res. 1997 Feb;12(2):283-9.
  6. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 Feb 6;326(6):381-6.
  7. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993 Jul 28;270(4):487-9.
  8. Leeper NJ, Kullo IJ, Cooke JP. Genetics of peripheral artery disease Circulation. 2012 Jun 26;125(25):3220-8.
  9. Peach G, Griffin M, Jones KG, Thompson MM, Hinchliffe RJ. Diagnosis and management of peripheral arterial disease. BMJ. 2012 Aug 14;345:e5208.
  10. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L; 1999-2000 national health and nutrition examination survey. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004 Jul;27(7):1591-7.
  11. Pollak AW, Norton PT, Kramer CM. Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions. Circ Cardiovasc Imaging. 2012 Nov;5(6):797-807.
  12. Stacy MR, Maxfield MW, Sinusas AJ. Targeted molecular imaging of angiogenesis in PET and SPECT: a review. Yale J Biol Med. 2012 Mar;85(1):75-86.
  13. Duran C, Bismuth J. Advanced imaging in limb salvage. Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):28-32.
  14. Segall GM, Lang EV, Lennon SE, Stevick CD. Functional imaging of peripheral vascular disease: a comparison between exercise whole-body thallium perfusion imaging and contrast arteriography. J NucI Med. 1992;33:1797-1800.
  15. Ohta T. Noninvasive technique using thallium‐201 for predicting ischaemic ulcer healing of the foot. Br J Surg. l985;72(11):892-895.
  16. Oshima M, Akanabe H, Sakuma S, Yano T, Nishikimi N, Shionoya S. Quantification of leg muscle perfusion using thallium-201 single photon emission computed tomography. J Nucl Med. 1989 Apr;30(4):458-65.
  17. Siegel ME, Siemsen JK. A new noninvasive approach to peripheral vascular disease: thallium-201 leg scans. AJR Am J Roentgenol. 1978 Nov;131(5):827-30.
  18. Seder JS, Botvinick EH, Rahimtoola SH, Goldstone J, Price DC. Detecting and localizing peripheral arterial disease: assessment of 201Tl scintigraphy. AJR Am J Roentgenol. 1981 Aug;137(2):373-80.
  19. Harbert J, Da Rocha AFG. Textbook of nuclear medicine. 2nd ed. New York: Lea Febriger; 1984.
  20. Lassen NA, Holstein P. Use of radioisotopes in assessment of distal blood flow and distal blood pressure in arterial insufficiency. Surg Clin North Am. 1974 Feb;54(1):39-55.
  21. Derezić D, Ivancević D, Custović F. The blood flow in the muscles of upper and lower extremities in patients with a chronic occlusive arterial disease, measured by the xenon-133 clearance technique. Acta Med Iugosl. 1980 Nov;34(4):279-87.
  22. Roon AJ, Moore WS, Goldstone J. Below-knee amputation: a modern approach. Am J Surg. 1977 Jul;134(1):153-8.
  23. Christian WJ, Schiepers CA, Siegel ME. Assessment of peripheral vascular perfusion of the lower extremities with hexaMlBl (RP-30): a new noninvasive approach. Radiology. l988;169(suppl):336.
  24. Dhekne RD, Moore WH, Ludwig EJ, Long SE. Skeletal muscle uptake of RP-30A in healthy individuals with stress and at rest. J Nucl Med 1988;29:775.
  25. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation. 1997;96(1):44-9.
  26. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300(24):1350-8.
  27. Miles KA, Barber RW, Wraight EP, Cooper M, Appleton DS. Leg muscle scintigraphy with 99Tcm-MIBI in the assessment of peripheral vascular (arterial) disease. Nucl Med Commun. 1992 Aug;13(8):593-603.
  28. Dabrowski J, Mikosiński J, Kuśmierek J. Scintigraphic and ultrasonographic assessment of the effect of lumbar sympathectomy upon chronic arteriosclerotic ischaemia of lower extremities. Nucl Med Rev Cent East Eur. 2003;6(1):17-22.
  29. Dabrowski J, Górski A, Mikosinski J. Applications of 99mTc MIBI perfusion scintigraphy for the evaluation of treatment results in patients with chronic arterial ischaemia of lower limbs. Acta Angiol.1996;2:149-254.
  30. Duet M, Virally M, Bailliart O, Kevorkian JP, Kedra AW, Benelhadj S, Ajzenberg C, Le Dref O, Guillausseau PJ. Whole-body (201)Tl scintigraphy can detect exercise lower limb perfusion abnormalities in asymptomatic diabetic patients with normal Doppler pressure indices. Nucl Med Commun. 2001 Sep;22(9):949-54.
  31. Tellier P, Lecouffe P, Vasseur C. Whole-body exercise thallium imaging in smokers. Vasc Med. 1998;3(1):15-20.
  32. Tellier P, Aquilanti S, Lecouffe P, Vasseur C. Comparison between exercise whole body thallium imaging and ankle-brachial index in the detection of peripheral arterial disease. Int Angiol. 2000 Sep;19(3):212-9.
  33. Cittanti C1, Colamussi P, Giganti M, Orlandi C, Uccelli L, Manfrini S, Azzena G, Piffanelli A. Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism. Eur J Nucl Med. 1997 Jul;24(7):762-6.
  34. Górski A, D¹browski J, Brykalski D, Stefańczyk L, Joss A. Ultrasonograficzna i izotopowa ocena wyników leczenia operacyjnego chorych z Zespołem Leriche a. Probl Med Nukl.1996; 10:139-146.
  35. Oshima M, Akanabe H, Sakuma S, Yano T, Nishikimi N, Shionoya S. Quantification of leg muscle perfusion using thallium-201 single photon emission computed tomography. J Nucl Med. 1989 Apr;30(4):458-65.
  36. Hamanaka D, Odori T, Maeda H, Ishii Y, Hayakawa K, Torizuka K. A quantitative assessment of scintigraphy of the legs using 201Tl. Eur J Nucl Med. 1984;9(1):12-6.
  37. Amin AM, Nawito ZO, Atfy RA, El-Hadidi KT. Tc-99m sestamibi lower extremity muscle scan, is it a useful screening tool for assessment of preclinical atherosclerosis in rheumatoid arthritis patients? Rheumatol Int. 2012 Jul;32(7):2075-81.
  38. Kuśmierek J, Dabrowski J, Bieńkiewicz M, Szumiński R, Płachcińska A. Radionuclide assessment of lower limb perfusion using 99mTc-MIBI in early stages of atherosclerosis. Nucl Med Rev Cent East Eur. 2006;9(1):18-23.

Files

Share

How to cite

Statistics